- US12599607utility2026Pharmaceutical Compositions Comprising Timolol0 cites
- US12569452utility2026Ophthalmic Compositions Comprising F6H80 cites
- US12496326utility2025Ophthalmic Composition for Treatment of Dry Eye Disease0 cites
- US12419933utility2025Ophthalmic Composition for the Treatment of Uveitis0 cites
- US12397039utility2025Compositions and Methods for the Treatment of Ocular Neovascularization0 cites
- US12310977utility2025Use of Semi-fluorinated Alkanes in Transdermal Therapeutic Systems0 cites
- US12226422utility2025Ophthalmic Compositions Comprising Tafluprost for the Treatment of Glaucoma0 cites
- US12128010utility2024Semifluorinated Compounds and Their Compositions0 cites
- US12059449utility2024Ophthalmic Composition for Treatment of Dry Eye Disease0 cites
- USRE050060reissue2024Topical Administration Method0 cites
- US12005033utility2024Compositions Comprising Mixtures of Semifluorinated Alkanes0 cites
- US11987623utility2024Stabilized Antibody Compositions0 cites
- US11896559utility2024Opthalmic Compositions Comprising F6H80 cites
- USRE049758reissue2023Stabilised Protein Compositions Based on Semifluorinated Alkanes0 cites
- US11723861utility2023Ophthalmic Compositions Comprising Latanoprost for Use in the Treatment of Ocular Diseases0 cites
- US11684589utility2023Pharmaceutical Compositions for Use in the Therapy of Blepharitis0 cites
- US11583513utility2023Semifluorinated Alkane Compositions0 cites
- US11576893utility2023Pharmaceutical Compositions Comprising Nebivolol0 cites